Nov 02, 2011 01:00 PM IST
Nirmal Bang has come out with its report on pharma space. Torrent Pharma and Glenmark Pharma owing to their discounted valuations and strong earnings trajectory are top Buy ideas, while Sun Pharmaceutical’s near-term growth looks fully priced in and therefore gets our Hold rating. We assign a Sell rating on Cipla and Cadila Healthcare.
- Oct 19, 2011 04:22 PM IST
Torrent Pharmaceuticals has reported a sales turnover of Rs 507.90 crore and a net profit of Rs 70.23 crore for the quarter ended Sep '11
- Jul 20, 2011 11:24 AM IST
Torrent Pharmaceuticals has got US FDA nod for generic of Sanofi's Uroxatral, reports CNBC-TV18, quoting NewsWire18. It touched a 52-week high of Rs 675. At 11:21 hrs the share was quoting at Rs 672.25, up Rs 8.55, or 1.29%.
- Mar 24, 2011 04:00 PM IST
Sushil Finance is bullish on Torrent Pharmaceuticals (TPL) and has recommended accumulate rating on the stock with a target of Rs 581 in its March 24, 2011 research report.
- Feb 28, 2011 07:14 AM IST
Drugmakers want tax exemption deadline for export oriented unit (EOUs) to be extended and want infrastructure or priority sector status in the budget on Feb 28.
- Jan 21, 2011 11:37 AM IST
Torrent Pharmaceuticals has reported a sales turnover of Rs 459.56 crore and a net profit of Rs 65.95 crore for the quarter ended Dec '10
- Jan 12, 2011 04:18 PM IST
Karvy Stock Broking has come out with its earning estimates on pharma sector for the quarter ended December 2010. According to the research firm, Torrent Pharmaceuticals December quarter sales are expected to go up by 18.6% at Rs 569.2 crore, Year-on-Year, (YoY) basis.